A detailed history of Gitterman Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gitterman Wealth Management, LLC holds 19,166 shares of NVO stock, worth $1.63 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
19,166
Previous 19,088 0.41%
Holding current value
$1.63 Million
Previous $2.72 Million 16.23%
% of portfolio
0.96%
Previous 1.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $9,287 - $11,342
78 Added 0.41%
19,166 $2.28 Million
Q1 2024

May 08, 2024

SELL
$102.11 - $135.92 $408,440 - $543,680
-4,000 Reduced 17.33%
19,088 $2.45 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $1.05 Million - $2.3 Million
11,544 Added 100.0%
23,088 $2.1 Million
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $19,185 - $21,235
-123 Reduced 1.05%
11,544 $1.87 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $397,020 - $477,419
-3,000 Reduced 20.45%
11,667 $1.86 Million
Q3 2022

Oct 27, 2022

SELL
$95.28 - $116.93 $89,753 - $110,148
-942 Reduced 6.03%
14,667 $1.46 Million
Q1 2022

May 12, 2022

SELL
$93.1 - $112.54 $141,605 - $171,173
-1,521 Reduced 8.88%
15,609 $1.73 Million
Q4 2021

Feb 01, 2022

BUY
$95.88 - $117.08 $9,492 - $11,590
99 Added 0.58%
17,130 $1.92 Million
Q3 2021

Nov 09, 2021

SELL
$84.42 - $106.62 $112,025 - $141,484
-1,327 Reduced 7.23%
17,031 $1.64 Million
Q2 2021

Jul 30, 2021

BUY
$67.66 - $84.76 $83,086 - $104,085
1,228 Added 7.17%
18,358 $1.54 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $1.15 Million - $1.3 Million
17,130 New
17,130 $1.16 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gitterman Wealth Management, LLC Portfolio

Follow Gitterman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gitterman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gitterman Wealth Management, LLC with notifications on news.